The effects of phenytoin on rat development: an animal model system for fetal hydantoin syndrome.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Teratology

• Publication date

  1981-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/TERA.1420240208PMID 7199765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The teratogenic potential of cacodylic acid in the rat and mouse.

  1981cited by this paper
• Phenytoin therapy and hemorrhagic disease.

  1980cited by this paper
• Folate antagonism following teratogenic exposure to diphenylhydantoin.

  1979cited by this paper
• Epilepsy Among Parents of Children with Facial Clefts

  1979cited by this paper
• Effect of phenytoin on bone and vitamin D metabolism

  1979cited by this paper
• Palate Morphology and Fetal Movements in Mice After DPH

  1979cited by this paper
• The effects of nutrition and enzyme induction in toxicology.

  1978cited by this paper
• Bone changes induced by diphenylhydantoin in chicks on a controlled vitamin D intake.

  1978cited by this paper
• Quantitation of anticonvulsant drugs in serum by gas-chromatography on the stationary phase SP-2510.

  1978cited by this paper
• The Effect of Diphenylhydantoin on Fibroblasts In Vitro

  1977cited by this paper
• Inhibition of cranial neural crest cell development by vitamin A in the cultured chick embryo.

  1977cited by this paper
• Fetal hydantoin syndrome.

  1976cited by this paper
• Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome.

  1976cited by this paper
• The fetal hydantoin syndrome.

  1975cited by this paper
• The neural crest in abnormalities of the face and brain.

  1975cited by this paper
• The pattogenesis of submucous cleft palate.

  1974cited by this paper
• Comparative embryotoxicity of diphenyldantoin and some of its metabolites in mice.

  1974cited by this paper
• Infants exposed in utero to antiepileptic drugs. A prospective study.

  1974cited by this paper
• Epilepsy and Pregnancy: A Report from the Oxford Record Linkage Study

  1973cited by this paper
• Diphenylhydantoin and selected congenital malformations.

  1973cited by this paper
• Inhibition of Protocollagen Proline Hydroxylase by Dilantin 1

  1973cited by this paper
• Placental transfer and neonatal elimination of diphenylhydantoin.

  1971cited by this paper
• Effects of phenobarbital or SKF 525A pretreatment on diphenylhydantoin disposition in pregnant mice.

  1971cited by this paper
• Introduction to Statistical Analysis. Third Edition.

  1970cited by this paper
• Congenital Abnormalities and Anticonvulsant Drugs

  1970cited by this paper
• Effect of phenobarbital and SKF 525A pretreatment on diphenylhydantoin teratogenicity in mice.

  1970cited by this paper
• A rapid method for detecting malformations in rat fetuses

  1969cited by this paper
• Relation of dosage and time of administration of diphenylhydantoin to its teratogenic effect in mice.

  1969cited by this paper
• Teratogenic effects of diphenylhydantoin sodium.

  1966cited by this paper
• The treatment of polycythaemia rubra vera with single doses of radioactive phosphorus.

  1958cited by this paper
• Macrocytosis and macrocytic anaemia caused by anticonvulsant drugs.

  1958cited by this paper

• Common Mechanism For Teratogenicity Of Antiepileptic Drugs

  2016cites this paper
• Fuz Mutant Mice Reveal Shared Mechanisms between Ciliopathies and FGF-Related Syndromes

  2013cites this paper
• ELUMA, FABIAN OBY THE TERATOLOGICAL EFFECTS OF DRUGS: CARBAMAZEPINE (CMZ), SODIUM VALPROATE (NaV) AND DIPHENYLHYDANTOIN (DPH); DOSAGE LEVELS, AND TIME OF DRUG ADMINISTRATION ON THE CRANIOFACIAL DEVELOPMENT IN THE CD-I MOUSE FETUS

  2012cites this paper
• Comparison of in vitro and in vivo developmental toxicity and pharmacokinetics of phenytoin in the rat.

  2008cites this paper
• The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin.

  2006cites this paper
• Craniofacial skeletal deviations following in utero exposure to the anticonvulsant phenytoin: monotherapy and polytherapy.

  2003cites this paper
• Common Mechanism for Teratogenicity of Antiepileptic Drugs: Drug-Induced Embryonic Arrhythmia and Hypoxia-Reoxygenation Damage

  2001cites this paper
• Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage.

  2001cites this paper
• Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.

  2001cites this paper
• Alterations in palatal ruga patterns in Jcl:ICR mouse fetuses from dams treated with all-trans-retinoic acid.

  2001cites this paper
• Palatal ruga anomaly induced by all-trans-retinoic acid in the Crj:SD rat: possible warning sign of teratogenicity.

  2001cites this paper
• Comparison of in vitro and in vivo Developmental Toxicity and Pharmacokinetics of Phenytoin in the Rat

  2000cites this paper
• Pharmacokinetic data support pharmacologically induced embryonic dysrhythmia as explanation to Fetal Hydantoin Syndrome in rats.

  2000cites this paper
• Skeletal-unit growth in the mandible of rats given diphenylhydantoin.

  1998cites this paper
• Chapter 40 – Animal/Human Concordance

  1998cites this paper
• Animal/Human Concordance

  1998cites this paper
• Biological Models in Radiopharmaceutical Development

  1995cites this paper
• All-trans-retinoic acid-induced variant patterns of palatal rugae in Crj:SD rat fetuses and their potential as indicators for teratogenicity.

  1995cites this paper
• Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction.

  1992cites this paper
• Diphenylhydantoin is not genotoxic in a battery of short-term cytogenetic assays.

  1992cites this paper
• A case with multiple abnormalities born to epileptic mother taking anticonvulsant drugs

  1991cites this paper
• Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies.

  1991cites this paper
• Developmental toxicity and pharmacokinetics of phenytoin in the rhesus macaque: an interspecies comparison.

  1990cites this paper
• Effect of sodium warfarin on vitamin K‐dependent proteins and skeletal development in the rat fetus

  1990cites this paper
• Developmental toxicity and pharmacokinetics of oral and intravenous phenytoin in the rat.

  1990cites this paper
• Effects of sodium valproate and oxygen on the craniofacial skeletal pattern in the CD-1 mouse embryo.

  1989cites this paper
• Prenatal exposure to phenytoin and its effect on postnatal growth and craniofacial proportion in the rat.

  1989cites this paper
• Behavioural teratology of exogenous substances: regulation aspects.

  1988cites this paper
• Arachidonic acid reversal of phenytoin-induced neural tube and craniofacial defects in vitro in mice.

  1988cites this paper
• Comparison of two methods for linear measurement of ossified tissue in cleared mouse fetuses.

  1988cites this paper
• Relationship between ossification and body weight of the CD-1 mouse fetus exposed in utero to anticonvulsant drugs.

  1986cites this paper
• Prenatal antiepileptic drug exposure alters seizure susceptibility in rats.

  1986cites this paper
• Teratogenic effects of valproate in the CD-1 mouse fetus.

  1985cites this paper
• Fetal hydantoin syndrome: inhibition of placental folic acid transport as a potential mechanism for fetal growth retardation in the rat.

  1985cites this paper
• Effects of anticonvulsant drugs on brain cultures from chick embryos: a comparison with cultures from embryos treated in ovo.

  1985cites this paper
• Comparison of the teratogenic potential of inhaled ethylene glycol monomethyl ether in rats, mice, and rabbits.

  1984cites this paper
• Lack of mutagenicity of diphenylhydantoin in in vitro short-term tests.

  1984cites this paper
• Human Serum Teratogenicity Studied by Rat Embryo Culture: Epilepsy, Anticonvulsant Drugs, and Nutrition

  1984cites this paper
• Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on craniofacial development in the CD-1 mouse fetus.

  1984cites this paper
• Effect of in utero exposure to anticonvulsants on craniofacial development and growth.

  1984cites this paper
• Four siblings with similar malformations after exposure to phenytoin and primidone.

  1984cites this paper
• Behavioral outcome after prenatal exposure to phenytoin in rats.

  1983cites this paper
• Embryology and Teratology

  1982cites this paper